Protein tyrosine phosphatases receptor type D is a potential tumour suppressor gene inactivated by deoxyribonucleic acid methylation in paediatric acute myeloid leukaemia

Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia

(2015) Yan-Fang Tao et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

PTPRDis Homozygously Deleted and Epigenetically Downregulated in Human Hepatocellular Carcinomas

(2015) Tolga Acun et al.   OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY

Deletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesis

(2015) Berenice Ortiz et al.   Oncotarget

SLC29A1 single nucleotide polymorphisms as independent prognostic predictors for survival of patients with acute myeloid leukemia: an in vitro study

(2014) Haixia Wan et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Reduced Expression of PTPRD Correlates with Poor Prognosis in Gastric Adenocarcinoma

(2014) Dandan Wang et al.   PLoS One

Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis

(2014) B. Ortiz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epigenetic silencing ofCHD5, a novel tumor-suppressor gene, occurs in early colorectal cancer stages

(2013) Mehrnaz Fatemi et al.   CANCER

Deregulation of protein phosphatase expression in acute myeloid leukemia

(2013) Nuzhat N. Kabir et al.   MEDICAL ONCOLOGY

Epigenetic regulation ofANKRD18Bin lung cancer

(2013) Wen-Bin Liu et al.   MOLECULAR CARCINOGENESIS

Expression of protein-tyrosine phosphatases in Acute Myeloid Leukemia cells: FLT3 ITD sustains high levels of DUSP6 expression

(2012) Deepika Arora et al.   Cell Communication and Signaling

Epigenetic regulation of DACT2, a key component of the Wnt signalling pathway in human lung cancer

(2012) Yan Jia et al.   JOURNAL OF PATHOLOGY

Molecular analysis of DNA repair gene methylation and protein expression during chemical-induced rat lung carcinogenesis

(2011) Wen-bin Liu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Epigenetics in AML

(2010) Ari M. Melnick   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicine

(2010) C. Bachas et al.   BLOOD

Single Nucleotide Polymorphism Array Analysis Defines a Specific Genetic Fingerprint for Well-Differentiated Cutaneous SCCs

(2009) Karin J. Purdie et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers

(2009) S. Veeriah et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mutational Inactivation of PTPRD in Glioblastoma Multiforme and Malignant Melanoma

(2008) D. A. Solomon et al.   CANCER RESEARCH

Convergence of Mutation and Epigenetic Alterations Identifies Common Genes in Cancer That Predict for Poor Prognosis

(2008) Timothy A Chan et al.   PLOS MEDICINE